These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 22112875)

  • 1. Medical management trumps stenting for intracranial arterial stenosis.
    Rosenberg K
    Am J Nurs; 2011 Dec; 111(12):16. PubMed ID: 22112875
    [No Abstract]   [Full Text] [Related]  

  • 2. Platelets and stents.
    Nemergut EC; Shaffrey ME
    J Neurosurg; 2007 Oct; 107(4):900-2; author reply 902. PubMed ID: 17937245
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of intracranial atherosclerotic stenosis.
    Turan TN; Chimowitz MI
    Rev Neurol Dis; 2008; 5(3):117-24. PubMed ID: 18838951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stenting versus aggressive medical therapy for intracranial arterial stenosis.
    Chimowitz MI; Lynn MJ; Derdeyn CP; Turan TN; Fiorella D; Lane BF; Janis LS; Lutsep HL; Barnwell SL; Waters MF; Hoh BL; Hourihane JM; Levy EI; Alexandrov AV; Harrigan MR; Chiu D; Klucznik RP; Clark JM; McDougall CG; Johnson MD; Pride GL; Torbey MT; Zaidat OO; Rumboldt Z; Cloft HJ;
    N Engl J Med; 2011 Sep; 365(11):993-1003. PubMed ID: 21899409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prasugrel: new drug. After angioplasty and stenting: continue to use aspirin + clopidogrel.
    Prescrire Int; 2009 Oct; 18(103):193-5. PubMed ID: 19877380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracranial stenosis: impact of randomized trials on treatment preferences of US neurologists and neurointerventionists.
    Turan TN; Cotsonis G; Lynn MJ; Wooley RH; Swanson S; Williams JE; Stern BJ; Derdeyn CP; Fiorella D; Chimowitz MI
    Cerebrovasc Dis; 2014; 37(3):203-11. PubMed ID: 24557055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angioplasty and stenting for atherosclerotic intracranial stenosis: rationale for a randomized clinical trial.
    Derdeyn CP; Chimowitz MI
    Neuroimaging Clin N Am; 2007 Aug; 17(3):355-63, viii-ix. PubMed ID: 17826637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Durability of endovascular therapy for symptomatic intracranial atherosclerosis.
    Mazighi M; Yadav JS; Abou-Chebl A
    Stroke; 2008 Jun; 39(6):1766-9. PubMed ID: 18420956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Dual platelet inhibition with clopidogrel and ASS. Who profits from the combination?].
    MMW Fortschr Med; 2003 Jul; 145(27-28):64. PubMed ID: 14587200
    [No Abstract]   [Full Text] [Related]  

  • 10. Have medical therapy and stenting been fairly compared? A repercussion upon termination of recruitment in the SAMMPRIS trial.
    Leung TW; Yu SC; Wong KS
    Int J Stroke; 2011 Aug; 6(4):312-4. PubMed ID: 21745340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Learning curve of Wingspan stenting for intracranial atherosclerosis: single-center experience of 95 consecutive patients.
    Yu SC; Leung TW; Lee KT; Wong LK
    J Neurointerv Surg; 2014 Apr; 6(3):212-8. PubMed ID: 23516268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clopidogrel protection is not increased further by ASS!].
    Bogousslavsky J
    Praxis (Bern 1994); 2004 Aug; 93(35):1390. PubMed ID: 15468578
    [No Abstract]   [Full Text] [Related]  

  • 13. Early aggressive medical management for patients with symptomatic intracranial stenosis.
    Nahab F; Kingston C; Frankel MR; Dion JE; Cawley CM; Mitchell B; Hammonds LP; Ayala L; Tong FC
    J Stroke Cerebrovasc Dis; 2013 Jan; 22(1):87-91. PubMed ID: 21795066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SAMMPRIS: end of intracranial stenting for atherosclerosis or back to the drawing board?
    Rahme RJ; Aoun SG; Batjer HH; Bendok BR
    Neurosurgery; 2011 Dec; 69(6):N16-8. PubMed ID: 22067345
    [No Abstract]   [Full Text] [Related]  

  • 15. Design of the stenting and aggressive medical management for preventing recurrent stroke in intracranial stenosis trial.
    Chimowitz MI; Lynn MJ; Turan TN; Fiorella D; Lane BF; Janis S; Derdeyn CP;
    J Stroke Cerebrovasc Dis; 2011; 20(4):357-68. PubMed ID: 21729789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Secondary prevention of TIA and stroke. How much must thrombocytes not be inhibited?].
    Einecke D
    MMW Fortschr Med; 2004 Jun; 146(24):50. PubMed ID: 15366495
    [No Abstract]   [Full Text] [Related]  

  • 17. [Emergency treatment of transient cerebral ischemia].
    Boysen G
    Ugeskr Laeger; 2008 Apr; 170(17):1475. PubMed ID: 18488296
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clopidogrel as basic therapy in high-risk stroke patients].
    Mattle HP
    Praxis (Bern 1994); 2004 Aug; 93(34):1364. PubMed ID: 15468694
    [No Abstract]   [Full Text] [Related]  

  • 19. Lessons from MATCH for future randomised trials in secondary prevention of stroke.
    Rothwell PM
    Lancet; 2004 Jul 24-30; 364(9431):305-7. PubMed ID: 15276368
    [No Abstract]   [Full Text] [Related]  

  • 20. Antiplatelet treatment for secondary prevention of acute ischemic stroke and transient ischemic attacks: mechanisms, choices and possible emerging patterns of use.
    Moonis M; Fisher M
    Expert Rev Cardiovasc Ther; 2003 Nov; 1(4):611-5. PubMed ID: 15030260
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.